Bioanalytical Services
 |
PharmaNet offers bioanalytical laboratory services through its subsidiaries: Anapharm, Anapharm Europe, Keystone Analytical and Taylor Technology.
Together, they offer over 1000 bioanalytical validated methods for one or more analytes from human or animal matrices.
Our laboratories can develop and validate custom (or project-specific) ELISAs or ligand-binding assays and can also develop and validate cell-based assays.
We are also actively working on developing proprietary methods that are not currently included in this list.
You may also view our list of biomarkers below.
List of BioMarkers
(Click here)
Contact us for more details.
(In alphabetically order)
Together, they offer over 1000 bioanalytical validated methods for one or more analytes from human or animal matrices.
Our laboratories can develop and validate custom (or project-specific) ELISAs or ligand-binding assays and can also develop and validate cell-based assays.
We are also actively working on developing proprietary methods that are not currently included in this list.
You may also view our list of biomarkers below.
List of BioMarkers
(Click here)
Contact us for more details.
(In alphabetically order)
 |
 |
 |
 |
 |
| Famotidine | Gastrointestinal | LC/MS | 0.5-200 ng/mL | Human EDTA Plasma |
| Felbinac | Pain | HPLC/FLR | 5-2000 ng/mL | Human Serum |
| Felodipine | Cardiovascular | LC/MS/MS | 20-10000 pg/mL | Human EDTA Plasma |
| Fenofibric Acid | Cardiovascular | LC/MS/MS | 50-25000 ng/mL | Dog EDTA Plasma |
| Fenofibric Acid | Cardiovascular | LC/MS/MS | 50-20000 ng/mL | Human EDTA Plasma |
| Fenofibric Acid | Cardiovascular | HPLC/UV | 50-25000 ng/mL | Human EDTA Plasma |
| Fentanyl | Pain | LC/MS/MS | 25-10000 pg/mL | Dog Serum |
| Fentanyl | Pain | LC/MS/MS | 10-5000 pg/mL | Human EDTA Plasma |
| Fentanyl | Pain | LC/MS/MS | 0.025-5 ng/mL | Human EDTA K3 Plasma |
| Fexofenadine | Respiratory | LC/MS/MS | 2-1000 ng/mL | Human EDTA Plasma |
| Fexofenadine | Respiratory | LC/MS/MS | 10-5000 ng/mL | Human Urine |
| Finasteride | Genitourinary | LC/MS/MS | 0.5-50 ng/mL | Human EDTA K3 Plasma |
| Finasteride | Genitourinary | LC/MS/MS | 0.5-200 ng/mL | Human EDTA Plasma |
| Flecainide | Cardiovascular | HPLC/FLR | 2-500 ng/mL | Human EDTA Plasma |
| Flosequinan | Cardiovascular | HPLC | 20-1600 ng/mL | Human Plasma |
| Flosequinan; Sulfone Metabolite | Cardiovascular | LC/MS/MS | 10-800 ng/mL | Human Heparinized Plasma |
| Fluconazole | Infectious Disease, Dermatology | LC/MS/MS | 50-7500 ng/mL | Human Sodium Heparinized Plasma |
| Fluorouracil | Oncology | LC/MS/MS | 5-2500 ng/mL | Human Sodium Heparinized Plasma |
| Fluorouracil | Oncology | LC/MS/Ms | 10-5000 ng/mL | Stabilized Human EDTA Plasma |
| Fluoxetine; Norfluoxetine | Central Nervous System Agents | LC/MS | 0.5-60 ng/mL | Human EDTA Plasma |
| Fluoxetine;Norfluoxetine;Ondansetron | LC/MS/MS | 2-1000 ng/mL;5-2500 ng/mL;2.5-1000 ng/mL | Rat Plasma | |
| Fluvastatin | Cardiovascular | LC/MS/MS | 5-400 ng/mL | Human Sodium Heparinized Plasma |
| Fluvoxamine | Central Nervous System Agents | LC/MS/MS | 0.5-200 ng/mL | Human EDTA Plasma |
| Fosinopril | Cardiovascular | LC/MS/MS | 100-10000 pg/mL | Human EDTA Plasma |
| Fosinoprilat | Cardiovascular | LC/MS/MS | 1-500 ng/mL | Human EDTA K3 Plasma |
| FSH (Follicle Stimulating Hormone) | Endocrinology | RIA | 2-100 mIU/mL | Human Serum |
| Furosemide | Cardiovascular | LC/MS/MS | 5-1000 ng/mL | Human Urine |
| Furosemide | Cardiovascular | LC/MS/MS | 50-4000 ng/mL | Human EDTA K2 Plasma |